# Mechanisms of Dural Involvement in Cerebral Amyloid Angiopathy

**Authors:** Marialuisa Zedde, Fabrizio Piazza, Rosario Pascarella

PMC · DOI: 10.3390/cells15010026 · Cells · 2025-12-23

## TL;DR

This paper explores how the dura mater and its lymphatic system may be involved in the buildup of amyloid in brain blood vessels, linking it to increased bleeding risks in elderly patients.

## Contribution

The study introduces the novel idea that the dura mater's lymphatic system may be involved in amyloid clearance and CAA progression.

## Key findings

- The dura mater and its lymphatic system may contribute to amyloid-beta clearance and cerebrospinal fluid homeostasis.
- A significant association exists between CAA and subdural hematoma, indicating increased hemorrhagic risk in CAA patients.

## Abstract

What are the main findings?
This study identifies the potential involvement of the dura mater and its lymphatic system in the pathophysiology of Cerebral Amyloid Angiopathy (CAA), suggesting that these structures may play a role in the clearance of amyloid-beta (Aβ) and maintenance of cerebrospinal fluid homeostasis.The research highlights a significant association between CAA and subdural hematoma (SDH), indicating that patients with CAA may face an increased risk of hemorrhagic complications, which complicates their clinical management.

This study identifies the potential involvement of the dura mater and its lymphatic system in the pathophysiology of Cerebral Amyloid Angiopathy (CAA), suggesting that these structures may play a role in the clearance of amyloid-beta (Aβ) and maintenance of cerebrospinal fluid homeostasis.

The research highlights a significant association between CAA and subdural hematoma (SDH), indicating that patients with CAA may face an increased risk of hemorrhagic complications, which complicates their clinical management.

What are the implications of the main findings?
Recognizing dural involvement in CAA emphasizes the need for further investigation into the role of meningeal lymphatics in amyloid clearance and cerebrovascular health, potentially leading to novel therapeutic approaches.Understanding the connection between CAA and SDH may guide clinicians in monitoring and treating patients more effectively, particularly in identifying those at higher risk for hemorrhagic events and adjusting management strategies accordingly.

Recognizing dural involvement in CAA emphasizes the need for further investigation into the role of meningeal lymphatics in amyloid clearance and cerebrovascular health, potentially leading to novel therapeutic approaches.

Understanding the connection between CAA and SDH may guide clinicians in monitoring and treating patients more effectively, particularly in identifying those at higher risk for hemorrhagic events and adjusting management strategies accordingly.

Cerebral Amyloid Angiopathy (CAA) is a neurovascular condition characterized by the accumulation of amyloid-beta (Aβ) in the walls of small blood vessels, particularly affecting the leptomeninges and cortical regions in elderly populations. Initially recognized for its association with spontaneous lobar intracerebral hemorrhage, recent studies have highlighted the broader implications of CAA on cognitive decline and vascular health. This narrative review aims to elucidate the mechanisms of dural involvement in CAA, an aspect that has been largely overlooked in existing literature. This paper provides a detailed examination of the potential role of the dura mater and its associated lymphatic system in the clearance of interstitial amyloid and the maintenance of cerebrospinal fluid (CSF) homeostasis. Dural lymphatic vessels may facilitate the efflux of Aβ from the brain, and any impairment in this drainage system could contribute to the pathological accumulation of amyloid, exacerbating CAA and its neurological consequences. Additionally, the significant association between CAA and subdural hematoma (SDH) has been explored, indicating that the presence of SDH may complicate the clinical management of CAA patients by signaling an increased risk of hemorrhagic events. The mechanisms linking CAA and SDH, including vascular fragility and chronic inflammatory processes, are discussed to provide insight into potential pathways for therapeutic intervention.

## Linked entities

- **Proteins:** ab (abrupt)
- **Diseases:** Cerebral Amyloid Angiopathy (MONDO:0005620), CAA (MONDO:0011921)

## Full-text entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** CAA (MESH:D016657), neurovascular condition (MESH:D013901), intracerebral hemorrhage (MESH:D002543), amyloid (MESH:C000718787), SDH (MESH:D006408), cognitive decline (MESH:D003072), hemorrhagic (MESH:D006470), inflammatory (MESH:D007249), vascular fragility (MESH:D005600)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12785828/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12785828/full.md

## References

187 references — full list in the complete paper: https://tomesphere.com/paper/PMC12785828/full.md

---
Source: https://tomesphere.com/paper/PMC12785828